Literature DB >> 10516609

Enumeration of CD4(+) T-cells in the peripheral blood of HIV-infected patients: an interlaboratory study of the FACSCount system.

A Lopez1, I Caragol, J Candeias, N Villamor, P Echaniz, F Ortuño, A Sempere, K Strauss, A Orfao.   

Abstract

The aim of the present study was to assess the interlaboratory reproducibility of the FACSCount system for the enumeration of peripheral blood (PB) CD4(+) T-cells. In each of the seven participating centers, both previously stained and unstained PB samples (n = 49) were received and either analyzed or stained and then analyzed. Interlaboratory reproducibility was checked in two different groups of centers (n = 3 and n = 4) where the study was performed in parallel. In addition, both the intralaboratory precision and accuracy of this system were analyzed in comparison with results obtained with conventional flow cytometry. Accordingly, upon comparing both methods, a high degree of correlation was observed in the total number of CD3(+) T-cells (coefficient of correlation of 0.9750 +/- 0.0184, slope of the best linear fit: 0. 9214 +/- 0.0311, y-intercept of 12 +/- 47) as well as in the number of CD3(+)/CD4(+) (coefficient of correlation of 0.9794 +/- 0.1457, slope of the best linear fit: 0.9463 +/- 0.0753, y-intercept of -11 +/- 36) and CD3(+)/CD8(+) (coefficient of correlation of 0.9728 +/- 0.0192, slope of the best linear fit: 0.9682 +/- 0.0735, y-intercept of 7 +/- 95) major subsets. In addition, low coefficients of variation (CV) were obtained for replicates, indicating the method's high degree of accuracy. The present study shows that with respect to the interlaboratory reproducibility reported for most techniques used for the enumeration of PB CD4(+) T-cells, the FACSCount system results in data with much lower coefficients of variance (CVs) (mean CV of less than 10%). Upon measuring the impact on results of different variables associated with either sample preparation or data acquisition and analysis, our study clearly shows that data acquisition and analysis does not influence the results by increasing variability since the coefficients of variation obtained for samples prepared in the same laboratory under the same conditions and read in different laboratories with different instruments were identical to those obtained for the replicates of the same samples read in each individual center. In contrast, interlaboratory variability, although low, significantly increased when sample preparation was carried out in different laboratories, suggesting that pipetting still represents the major source of variability in the FACSCount system. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10516609     DOI: 10.1002/(sici)1097-0320(19991015)38:5<231::aid-cyto5>3.0.co;2-y

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  13 in total

1.  Use of formalin-fixed, propidium iodide-stained human leukocytes as a standard for enumerating CD4+ T lymphocytes in a single-platform assay.

Authors:  G M Harrison; A J Bennett; M Moody; G F Read; P E Williams
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

2.  Low CD4+ T-lymphocyte values in human immunodeficiency virus-negative adults in Botswana.

Authors:  Hermann Bussmann; C William Wester; Kereng V Masupu; Trevor Peter; Sarah M Gaolekwe; Soyeon Kim; Ann Marie Reich; Sam Ahn; Ying Wu; Ibou Thior; Max Essex; Richard Marlink
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

3.  Diagnostic accuracy and clinical utility of a simplified low cost method of counting CD4 cells with flow cytometry in Malawi: diagnostic accuracy study.

Authors:  Calman A MacLennan; Michael K P Liu; Sarah A White; Joep J G van Oosterhout; Felanji Simukonda; Joseph Bwanali; Michael J Moore; Eduard E Zijlstra; Mark T Drayson; Malcolm E Molyneux
Journal:  BMJ       Date:  2007-07-17

Review 4.  Point-of-care diagnostics to improve maternal and neonatal health in low-resource settings.

Authors:  Catherine E Majors; Chelsey A Smith; Mary E Natoli; Kathryn A Kundrod; Rebecca Richards-Kortum
Journal:  Lab Chip       Date:  2017-10-11       Impact factor: 6.799

5.  Laboratory and field evaluation of the Partec CyFlow miniPOC for absolute and relative CD4 T-cell enumeration.

Authors:  Djibril Wade; Papa Alassane Diaw; Géraldine Daneau; Abdoul Aziz Diallo; Souleymane Mboup; Tandakha Ndiaye Dieye; Luc Kestens
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

Review 6.  CD4 enumeration technologies: a systematic review of test performance for determining eligibility for antiretroviral therapy.

Authors:  Rosanna W Peeling; Kimberly A Sollis; Sarah Glover; Suzanne M Crowe; Alan L Landay; Ben Cheng; David Barnett; Thomas N Denny; Thomas J Spira; Wendy S Stevens; Siobhan Crowley; Shaffiq Essajee; Marco Vitoria; Nathan Ford
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

7.  Evaluation of PIMATM CD4 System for Decentralization of Immunological Monitoring of HIV-Infected Patients in Senegal.

Authors:  Babacar Faye; Moustapha Mbow; Mame Cheikh Seck; Babacar Mbengue; Djiril Wade; Makhtar Camara; Cathy Cissé; Salimata Guèye Diouf; Babacar Ndao; Audrey Djibo; Maguette Dème Sylla Niang; Tandakha Ndiaye; Michael P Grillo; Alioune Dièye
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

8.  CD4 T-cell enumeration in a field setting: evaluation of CyFlow counter using the CD4 easy count kit-dry and Pima CD4 systems.

Authors:  Djibril Wade; Papa Alassane Diaw; Géraldine Daneau; Makhtar Camara; Tandakha Ndiaye Dieye; Souleymane Mboup; Luc Kestens
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

9.  Affordable pediatric CD4 counting by flow cytometry in Malawi.

Authors:  Calman A Maclennan; Felix Dzumani; Alinane Namarika; Peter Moons; Edward Senga; Malcolm E Molyneux; Mark T Drayson; James E G Bunn
Journal:  Cytometry B Clin Cytom       Date:  2008       Impact factor: 3.058

10.  An integrated tiered service delivery model (ITSDM) based on local CD4 testing demands can improve turn-around times and save costs whilst ensuring accessible and scalable CD4 services across a national programme.

Authors:  Deborah K Glencross; Lindi M Coetzee; Naseem Cassim
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.